Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Astrazeneca Plc (AZN.LN)

Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 211,024,594
  • Shares Outstanding, K 1,550,284
  • Annual Sales, $ 54,073 M
  • Annual Income, $ 7,035 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 4.86
  • Price/Cash Flow 18.77
  • Price/Book 6.15
  • Price/Earnings ttm 30.22
  • Earnings Per Share ttm 6.02
  • Most Recent Earnings $1.62 on 11/06/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 3.13 (1.80%)
  • Most Recent Dividend 0.767 on 08/07/25
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
13,361.998 +1.02%
on 12/12/25
14,206.002 -4.98%
on 11/26/25
-68.004 (-0.50%)
since 11/18/25
3-Month
10,784.000 +25.17%
on 09/26/25
14,206.002 -4.98%
on 11/26/25
+2,249.998 (+20.00%)
since 09/18/25
52-Week
9,573.505 +40.99%
on 04/09/25
14,206.002 -4.98%
on 11/26/25
+3,145.998 (+30.39%)
since 12/18/24

Most Recent Stories

More News
UK will increase its spending on medicine under a zero-tariff deal with the US

Officials say the U.K. has sealed a deal securing a 0% tariff rate for all U.K. medicines exported to the U.S. for at least three years, in return for the U.K. spending more on new medicine

AZN.LN : 13,472.000 (-0.60%)
Trump unveils deal to expand coverage and lower costs on obesity drugs

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy

AZN.LN : 13,472.000 (-0.60%)
PFE : 25.04 (-1.92%)
AstraZeneca's 9M and Q3 2025 Financial Results

Continued strong commercial performance and unprecedented pipeline delivery in the year to date

AZN : 89.86 (-1.63%)
AZN.LN : 13,472.000 (-0.60%)
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal

AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration

$SPX : 6,721.43 (-1.16%)
AZN.LN : 13,472.000 (-0.60%)
$DOWI : 47,885.97 (-0.47%)
ABNB : 133.78 (+1.34%)
$IUXX : 24,647.61 (-1.93%)
PFE : 25.04 (-1.92%)
Trump to put import taxes on pharmaceutical drugs, kitchen cabinets, furniture and heavy trucks

President Donald Trump is putting import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on Oct. 1

JNJ : 210.33 (+0.49%)
AZN.LN : 13,472.000 (-0.60%)
FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz

The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy

HIMS : 34.97 (-5.13%)
AZN.LN : 13,472.000 (-0.60%)
Why value investing has worked better outside the US

What lessons does value investing’s success abroad hold for value investors everywhere

$SPX : 6,721.43 (-1.16%)
AZN.LN : 13,472.000 (-0.60%)
MORN : 213.89 (+2.00%)
$DOWI : 47,885.97 (-0.47%)
$IUXX : 24,647.61 (-1.93%)
AstraZeneca results: H1 and Q2 2025

Strong growth momentum continues with excellent R&D pipeline delivery in the year-to-date

AZN : 89.86 (-1.63%)
AZN.LN : 13,472.000 (-0.60%)
A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today

COMP : 10.53 (-3.22%)
NFLX : 94.79 (+0.23%)
$NASX : 22,693.32 (-1.81%)
$SPX : 6,721.43 (-1.16%)
AZN.LN : 13,472.000 (-0.60%)
TEM : 64.61 (-5.13%)
The Promise of Quantum Computing

The race to quantum supremacy is on. While this future will not come tomorrow, big tech companies are building to the technology's "ChatGPT moment."

NFLX : 94.79 (+0.23%)
NVDA : 170.94 (-3.81%)
GOOGL : 296.72 (-3.21%)
GOOG : 298.06 (-3.14%)
HON : 199.89 (+0.82%)
SENEA : 111.60 (+0.84%)
IONQ : 45.85 (-7.69%)
RGTI : 22.47 (-6.22%)
AMGN : 326.01 (-0.22%)
MSFT : 476.12 (-0.06%)
AZN : 89.86 (-1.63%)
IBM : 303.32 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 13,793.996
2nd Resistance Point 13,737.998
1st Resistance Point 13,645.998
Last Price 13,472.000
1st Support Level 13,498.000
2nd Support Level 13,442.002
3rd Support Level 13,350.002

See More

52-Week High 14,206.002
Last Price 13,472.000
Fibonacci 61.8% 12,436.388
Fibonacci 50% 11,889.754
Fibonacci 38.2% 11,343.118
52-Week Low 9,573.505

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar